Finerenone

Finerenone（CAS 1050477-31-0）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

公开数据库收录的理化数据

这个物质在各数据库里的编号

数据库记载的用途

• Finerenone is a selective, nonsteroidal mineralocorticoid receptor antagonist that is used in the therapy of chronic renal disease in patients with type 2 diabetes to slow progression of renal dysfunction and reduce the risk of cardiovascular disease morbidity and mortality. Finerenone has not been linked to serum enzyme elevations during therapy or with instances of clinically apparent liver injury.
• Breast Feeding; Lactation; Mineralocorticoid Receptor Antagonists
• Avoid grapefruit products. Grapefruit products may increase exposure to finerenone, increasing the risk and severity of adverse effects.
• Take with or without food. Food does not have a clinically significant effect on area under the curve.
• Established Pharmacologic Class [EPC] - Nonsteroidal Mineralocorticoid-Receptor Antagonist
• Mechanisms of Action [MoA] - Mineralocorticoid Receptor Antagonists

它在各数据库里的别名

Finerenone; 1050477-31-0; Kerendia; (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide; BAY94-8862; BAY 94-8862; finerenona; finerenonum; DE2O63YV8R; BAY-94-8862; (4S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxamide; DTXSID10146928; RefChem:57201; DTXCID5069419; 814-499-5; Finerenone (BAY 94-8862)

计算机算出的分子描述符

数据库摘要

Finerenone · CAS 1050477-31-0 · C21H22N4O3. UNII DE2O63YV8R. LogP: 2.51.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。